{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:27Z","timestamp":1790226087158,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijp.ijp_633_16","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T02:31:02Z","timestamp":1544754662000},"page":"266","source":"Crossref","is-referenced-by-count":6,"title":["Oxaceprol versus tramadol for knee osteoarthritis: A randomized controlled trial"],"prefix":"10.4103","volume":"50","author":[{"given":"Avijit","family":"Hazra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Ghorai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmalKanti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.247538-1","first-page":"2163","volume-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.247538-2","first-page":"113","volume-title":"The epidemiology of osteoarthritis in Asia","author":"Fransen","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"key-10.4103\/0253-7613.247538-3","unstructured":"Sharma R. Epidemiology of Musculoskeletal Conditions in India. New Delhi: Indian Council of Medical Research; 2012."},{"key":"key-10.4103\/0253-7613.247538-4","first-page":"614","volume-title":"Is there an urban-rural divide.Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model?","author":"Joshi","year":"2009","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0253-7613.247538-5","first-page":"407","volume-title":"Biological aspects of early osteoarthritis","author":"Madry","year":"2012","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"key-10.4103\/0253-7613.247538-6","first-page":"465","volume-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key-10.4103\/0253-7613.247538-7","first-page":"209","volume-title":"Antirheumatic agents and leukocyte recruitment.New light on the mechanism of action of oxaceprol","author":"Parnham","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0253-7613.247538-8","first-page":"293","volume-title":"Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis","author":"Veihelmann","year":"2001","journal-title":"Acta Orthop Scand"},{"key":"key-10.4103\/0253-7613.247538-9","first-page":"579","volume-title":"Effect of oxaceprol on the synthesis and degradation in vitro of proteoglycans and proteins by calf articular cartilage explants","author":"Riera","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"key-10.4103\/0253-7613.247538-10","first-page":"136","volume-title":"Autoradiography studies of the effect of oxaceprol on the metabolism of joint cartilage in vitro and in vivo","author":"Kalbhen","year":"1987","journal-title":"Z Rheumatol"},{"key":"key-10.4103\/0253-7613.247538-11","first-page":"4","volume-title":"Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip","author":"Bauer","year":"1999","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/0253-7613.247538-12","first-page":"99","volume-title":"Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac","author":"Herrmann","year":"2000","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/0253-7613.247538-13","first-page":"29","volume-title":"Oxaceprol \u2013 A randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug","author":"Kr\u00fcger","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/0253-7613.247538-14","first-page":"24","volume-title":"Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: A systematic review and network meta-analysis","author":"Kongtharvonskul","year":"2015","journal-title":"Eur J Med Res"},{"key":"key-10.4103\/0253-7613.247538-15","first-page":"962","volume-title":"Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: Systematic analytic review","author":"Smith","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"key-10.4103\/0253-7613.247538-16","first-page":"CD005522","volume-title":"Tramadol for osteoarthritis","author":"Cepeda","year":"2006","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:38:31Z","timestamp":1786714711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_633_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["247538"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_633_16","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}